Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Bolus vs Continuous for Post-Extubation Cough
NCT06040034Phase 2Completed
- Sponsor
- Universitas Padjadjaran
- Start
- Feb 2023
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in cough (2 arms), sponsored by Universitas Padjadjaran. Primary endpoint: Post-Extubation Cough Grade. Started Feb 2023; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
cough
Beyond the preview
Go deeper on NCT06040034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06040034.